Notably, a comprehensive meta-analysis involving 6010 BC patients revealed that c-MET overexpression was associated with 1.41-fold increased risk of recurrence in ER+/HER2- resected BC patients, likely due to the induction of EMT gene expression signature supporting cancer metastases [22]. This evidence concerns the gene ERBB2 and cancer.